Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2008
08/20/2008CN100411634C Medication for treating liver disease, and preparation method
08/20/2008CN100411631C Orally administered compound antihyperlipidemic
08/20/2008CN100411629C Slow-released type iron-complement agent preparation method
08/20/2008CN100411626C Preparing method of slow-released type iodine complement agent
08/20/2008CN100411620C Use of dipyridazole or mopidamol in the manufacture of a medicament for treatment and prevention of fibrin-dependent microcirculation disorders
08/20/2008CN100411619C Composition for suppressing blood sugar ascending
08/20/2008CN100411618C Use of compounds that are effective as selective opiate receptor modulators
08/20/2008CN100411615C Effect of aminoguanidine for curing wound surface in refractory to treatment
08/20/2008CN100411612C Quick-disintegration tablets of calcium atovastatine, and its preparation method
08/20/2008CN100411608C Method of preparing a formulation containing a microdosed active component
08/19/2008US7414140 Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them
08/19/2008US7414122 host cell, viral vector; agonists and antagonists; diagnosis or treatment of cancer; antiproliferative; infertility, miscarriage, preterm labor and delivery, and endometriosis; immunosuppressants; vaccine adjuvants; genetic mapping
08/19/2008US7414107 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
08/19/2008US7414077 Therapeutic intervention to mimic the effect of caloric restriction
08/19/2008US7414075 capsinoid substance selected from the group consisting of 4-hydroxy-3-methoxybenzyl (E)-8-methyl-6-nonenoate and 4-hydroxy-3-methoxybenzyl 8-methylnonanoate; treating arthrosclerosis
08/19/2008US7414072 Aryl 5-thio-β-d-glucopyranoside derivatives and therapeutic agents for diabetes containing the same
08/19/2008US7414070 Indol-7-YL sulfonamide derivatives, their preparation and their use in pharmaceutical compositions
08/19/2008US7414057 Piperazine urea derivatives as melanocortin-4 receptor agonists
08/19/2008US7414054 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
08/19/2008US7414048 4,5-dihydro-isoxazole derivatives and their pharmaceutical use
08/19/2008US7413750 Process for producing solid oral dosage forms with sustained release of active ingredient
08/19/2008US7413740 Cholesterol-lowering agents, secondary bile acid production inhibitors and foods and drinks
08/19/2008CA2501543C Enhancement of alcohol metabolism
08/19/2008CA2461567C Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
08/19/2008CA2432799C Pyrazole compounds useful as protein kinase inhibitors
08/19/2008CA2241469C Tetrahydroimidazo [2,1-a] isoquinoline derivatives
08/14/2008WO2008098211A1 Treatment of glaucoma and diabetic retinopathy with morinda citrifolia enhanced formulations
08/14/2008WO2008098162A1 Methods and materials for reducing or eliminating risk factors associated with syndrome x
08/14/2008WO2008097976A1 Heterocyclic modulators of tgr5 for treatment of disease
08/14/2008WO2008096905A1 Anti-brak (cxcl14) human monoclonal antibody and use thereof
08/14/2008WO2008096870A1 Aza-bridged-ring compound
08/14/2008WO2008096841A1 Dimerized cyclo derivative
08/14/2008WO2008096829A1 Tricyclic compounds
08/14/2008WO2008096826A1 Prophylactic agent for autoimmune disease
08/14/2008WO2008096820A1 Biphenyl derivative
08/14/2008WO2008096781A1 Betacellulin mutein
08/14/2008WO2008096769A1 Pharmaceutical compositions containing substituted cercosporamide derivatives
08/14/2008WO2008096755A1 Vanilloid receptor (vr1) inhibitor and use thereof
08/14/2008WO2008096746A1 Spiro compound and use thereof
08/14/2008WO2008096690A1 Polyethylene glycol derivative
08/14/2008WO2008096260A1 3-amino-pyrrolo[3,4-c] pyrazole- 5 (1h, 4h, 6h) carbaldehyde derivatives as pkc inhibitors
08/14/2008WO2008096200A2 Purifier device for burnt gases from internal combustion engines
08/14/2008WO2008096021A2 Process for continuous production of lovastatine
08/14/2008WO2008095823A1 5 -amido- (ih- indol- 2 -yl) piperazin-1-yl-methanone derivatives as histamine h3 receptor ligands
08/14/2008WO2008095821A1 Indol-2-yl-piperazin-1-yl-methanone derivatives
08/14/2008WO2008095820A1 (indol-4-yl)- or (indol-5-yl)-piperazinylmethanone derivatives for the treatment of obesity
08/14/2008WO2008095366A1 Porphyrin derivatives, preparation methods and the uses as small molecular antioxidant thereof
08/14/2008WO2008095275A1 Methods for the treatment of senile dementia of the alzheimer's type
08/14/2008WO2008079610A3 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
08/14/2008WO2008076810A3 Azabicyclic heterocycles as cannabinoid receptor modulators
08/14/2008WO2008039087A3 Indoline derivatives and uses thereof
08/14/2008WO2008033468A3 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism
08/14/2008US20080194703 Method of Preparing Lycopene-Enriched Formulations That are Free of Organic Solvents, Formulations Thus Obtained, Compositions Comprising Said Formulations and Use of Same
08/14/2008US20080194698 administering N-methyl-D-aspartate receptor antagonists, preferably memantine, neramexane or prodrugs; treatment of obesity, eating disorders and/or regulation of appetites
08/14/2008US20080194672 Growth hormone secretagogue (ghrelin) receptor; gastrointestinal disorders; gastroesophageal reflux disease (GERD), gastric ulcers, Crohn's disease
08/14/2008US20080194665 Compositions Based on Amino Acids for Improving the Myocardial Ventricular Function in Patients Suffering from Diabetes
08/14/2008US20080194656 Benzotriazole Derivatives as Cannabinoid Receptor Antagonists
08/14/2008US20080194646 Using phenoxyacetic acid as anticancer agents; peroxisome proliferator activator moderator
08/14/2008US20080194643 Using pyrrolidonedicarboxamide compound; therapy for thrombosis, cardiovascular disorders; myocardoim infraction; restenosis; atherosclerosis; anticancer agents; sepsis; antidiabetic agents
08/14/2008US20080194625 Tetrahydroquinoline derivatives as cannabinoid receptor modulators
08/14/2008US20080194617 Fused ring compound
08/14/2008US20080194614 Using mixture of hydroxy-3-methylglutaryl coenzyme a inhibitor and rapamycin; anticholesterol agents; dyslipidemia; atherosclerosis; antiarthritic agents; inflammatory bowel disorders; restenosis; transplant rejection
08/14/2008US20080194609 Chemical Compound and Its Use
08/14/2008US20080194608 Atherosclerosis therapy; antidiabetic agents; dyslipidemia
08/14/2008US20080194586 Controlling non-insulin dependent diabetes; hypoglycemic agents; antilipemic agents; hypercholesterolemia; obesity
08/14/2008US20080194581 Pyrrole derivatives, intermediates therefor, preparation and therapeutic use thereof
08/14/2008US20080194575 Treatment for non-alcoholic-steatohepatitis
08/14/2008US20080194564 the use thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions comprising them, and processes for the preparation of these
08/14/2008US20080194563 small molecule protein tyrosine phosphatase inhibitorsuse of said compounds for the treatment of phosphatase-mediated diseases, especially cancer
08/14/2008US20080194530 Chemical Compounds
08/14/2008US20080194525 Process of Making Geminal Bisphosphonic Acids and Pharmaceutically Acceptable Salts and/or Hydrates Thereof
08/14/2008US20080194499 Solvent extraction of a plant extract from Centella asiatica; removing fatty substances and chlorophyll; purification by HPLC; concentrating the eluent to obtain pentacyclic terpenoid glycosides, preferably asiaticoside and madecassoside; obesity
08/14/2008US20080194495 1-amino-2,3-dihydroxy-5-hydroxymethyl-cyclopent-4-yl 4-O-(6-deoxy- alpha -D-glucopyranosyl)- alpha -D-glucopyranoside; alpha-amylase inhibitor; antidiabetic agents, hypoglycemic agents; side effect reduction
08/14/2008US20080194494 4-Biarylyl-1-Phenylazetidin-2-One Glucuronide Derivatives for Hypercholesterolemia
08/14/2008US20080194493 Compositions Containing D-Carnosine
08/14/2008US20080194492 Use of gamma-glutamyl-peptide for example gamma-L-glutamyltrans-S-1-propenyl-L-cysteine sulfoxide (GPCS); Paget's disease, tumor-induced bone disease or osteoporosis; ethanolic extract of allium such as Allium cepa (onion); nutraceuticals
08/14/2008US20080194485 Use of a prolylcarboxypeptidase (PRCP) inhibitor to treat or prevent obesity; use for example t-butyl carbamate-prolyl prolinal (B-PP), N-benzyloxycarbonyl-prolyl-prolinal (Z-PP), diisopropyl fluorophosphate, PMSF, antipain, leupeptin, corn trypsin, and mercuric chloride
08/14/2008US20080194483 GLP-1 (9-36) methods and compositions
08/14/2008US20080194482 VPAC2 receptor peptide agonists of given amino acid sequences; PACAP-preferring type 2 (PAC2) receptor; VIP-shared type 2 receptors (VPAC2); induce insulin secretion from the pancreas only in the presence of high blood glucose levels; side effect reduction; diabetes
08/14/2008US20080194462 Methods and Compositions for Treatment of Autoimmune Diseases
08/14/2008US20080194461 Stabilizing Alkylglycoside Compositions and Methods Thereof
08/14/2008US20080193444 Methods of suppressing LTP inhibition
08/14/2008US20080193426 Increasing homing of CD34 by administering chemokines, fusion protein; irradiation, cyclophosphamide or 5-fluorouracil; interleukins; Gaucher disease
08/14/2008CA2700585A1 Food extracts for treatment of lipoprotein abnormalities and skin diseases and skin disorders
08/14/2008CA2678194A1 Anti-human brak (cxcl14) monoclonal antibody and use thereof
08/14/2008CA2678193A1 Aza-bridged-ring compound
08/14/2008CA2677661A1 Tricyclic compounds
08/14/2008CA2677263A1 Compounds and compositions as modulators of gpr119 activity
08/14/2008CA2677233A1 Prophylactic agent for autoimmune disease
08/14/2008CA2676678A1 (indol-4-yl)- or (indol-5-yl)-piperazinylmethanone derivatives for the treatment of obesity
08/14/2008CA2676268A1 5 -amido- (ih- indol- 2 -yl) piperazin-1-yl-methanone derivatives as histamine h3 receptor ligands
08/14/2008CA2676265A1 Indol-2-yl-piperazin-1-yl-methanone derivatives
08/14/2008CA2676146A1 Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
08/13/2008EP1956090A1 Novel protein and dna encoding the protein
08/13/2008EP1956020A2 1-[2-(heterocyclyl-aminomethyl)-piperidin-1-YL]-1-(2-methyl-5-phenyl-heterocyclyl)-methanone derivatives and related compounds as orexin-1 antagonists for the treatment of obesity
08/13/2008EP1956019A1 Benzoquinazoline derivatives
08/13/2008EP1956013A1 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition
08/13/2008EP1956004A1 Quinoline derivatives and their use as 5-HT6 ligands
08/13/2008EP1955707A1 Pharmaceutical composition for prevention or treatment of neurogenic pain
08/13/2008EP1955701A1 Polyacetylenic compounds
1 ... 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 ... 1298